Hapvida and Notre Dame Intermédica have told the Brazilian competition authority that their deal will result in more "competitive prices" in the healthcare plan market and "more effective" services. They also said that without their merger, rivals Unimed, Sul América, Amil and Bradesco won't face pressure to improve their services."If the deal